Not checked for notices yet.
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
Sigrid Jall, Stephan Sachs, Christoffer Clemmensen and 6 more
Molecular Metabolism · 2017
doi:10.1016/j.molmet.2017.02.002
Cited by papers we hold 3
- GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives · 2023No notice
- Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors · 2022No notice
- Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.